Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-16

Clinical Trial Update: Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects [Phase 3]

View source ↗

Summary

This clinical trial update reports a Phase 3 study evaluating the efficacy and safety of rimegepant as a preventive treatment for migraine in pediatric patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NURTEC ODT (RIMEGEPANT SULFATE)

Snippet

Sponsor: Pfizer | Conditions: Migraine | Phase 3 | Status: RECRUITING